iCAD And Windsong Radiology Ink Strategic Commercial Agreement To Implement AI-Powered Mammography
Portfolio Pulse from Benzinga Newsdesk
iCAD, Inc. (NASDAQ:ICAD) has announced a strategic agreement with Windsong Radiology Group to implement its AI-powered mammography solution, ProFound AI Breast Health, at Windsong Radiology center locations.
July 29, 2024 | 12:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
iCAD, Inc. has entered into a strategic agreement with Windsong Radiology Group to implement its AI-powered mammography solution, ProFound AI Breast Health, at Windsong Radiology center locations.
The strategic agreement with Windsong Radiology Group is likely to enhance iCAD's market presence and drive revenue growth by expanding the adoption of its AI-powered mammography solutions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100